Biochem Biophys Res Commun

1. DE OLIVEIRA THC, Goncalves GKN
   Complement system: A key player in hepatic ischemia-reperfusion injury.
   Biochem Biophys Res Commun. 2025;783:152580.
   

   >> Share

   
   

   
   Cancer

2. JUDGE SJ, Manin E, Chou J, Torphy RJ, et al
   Influence of biologic sex and obesity on liver recurrence and survival in patients undergoing upfront surgery for pancreatic adenocarcinoma.
   Cancer. 2025;131:e70088.
   

   >> Share

   
   

   
   Cancer Res

3. CUI G, Zhou Y, Liao W, Cossu E, et al
   Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma.
   Cancer Res. 2025 Sep 12. doi: 10.1158/0008-5472.CAN-25-1615.
   

   >> Share

   
   

   
   Dig Dis Sci

4. CULLARO G, Allegretti AS, Patidar KR, Verna EC, et al
   Embracing Imperfect Tools to Decode AKI in Decompensated Cirrhosis.
   Dig Dis Sci. 2025 Sep 7. doi: 10.1007/s10620-025-09379.
   

   >> Share

   
   
5. NG N, Purkayastha S, Ying X, Jesudian A, et al
   Socioeconomic Factors Impact the Perception of Healthcare Experiences in Patients with Cirrhosis.
   Dig Dis Sci. 2025 Sep 6. doi: 10.1007/s10620-025-09374.
   

   >> Share

   
   

   
   Endoscopy

6. SUMIDA Y, Fujigaki S, Uekado H, Sugao H, et al
   Reintervention using cholangioscopy for metallic stent obstruction following endoscopic ultrasound-guided hepaticogastrostomy.
   Endoscopy. 2025;57.
   

   >> Share

   
   
7. ASSAF A, Ratone JP, Hoibian S, Dahel Y, et al
   Endoscopic ultrasound-guided hepaticoduodenostomy for the management of iatrogenic bile duct injury related to cholecystectomy: a report of two cases.
   Endoscopy. 2025;57.
   

   >> Share

   
   
8. MIWA H, Ishino Y, Endo K, Oishi R, et al
   Down-angulation puncture method to avoid vascular injury during endoscopic ultrasound-guided hepaticogastrostomy.
   Endoscopy. 2025;57.
   

   >> Share

   
   
9. MARUYAMA H, Ishikawa-Kakiya Y, Kawata Y, Kurokawa T, et al
   Endoscopic ultrasonography-guided hepaticogastrostomy using spatial reality display navigation capable of naked-eye stereopsis.
   Endoscopy. 2025;57.
   

   >> Share

   
   

   
   Eur Radiol

10. LUDEMANN WM, Kahn J, Pustelnik D, Hardt J, et al
    Correction: Yttrium-90 radioembolization for unresectable hepatocellular carcinoma: predictive modeling strategies to anticipate tumor response and improve patient selection.
    Eur Radiol. 2025 Sep 11. doi: 10.1007/s00330-025-11907.
    

    >> Share

    
    
11. TAO Y, Song M, Zhang H, He H, et al
    Large well-differentiated hepatocellular carcinoma in patients with HBV: gadoxetic acid-enhanced MR imaging features and prognosis.
    Eur Radiol. 2025 Sep 12. doi: 10.1007/s00330-025-11994.
    

    >> Share

    
    
12. MATHUR A, Ozkaya E, Rosberger S, Sigel KM, et al
    Concordance of vibration-controlled transient elastography and magnetic resonance elastography for fibrosis staging in patients with metabolic dysfunction-associated steatotic liver disease.
    Eur Radiol. 2025;35:6507-6515.
    

    >> Share

    
    
13. DIOGUARDI BURGIO M, Ronot M, Vilgrain V
    ESR Essentials: assessing the radiological response of liver metastases to systemic therapy-practice recommendations by the European Society of Gastrointestinal and Abdominal Radiology.
    Eur Radiol. 2025;35:6516-6526.
    

    >> Share

    
    
14. NJOLSTAD TH, Jensen K, Andersen HK, Berstad AE, et al
    Deep learning reconstruction for detection of liver lesions at standard-dose and reduced-dose abdominal CT.
    Eur Radiol. 2025;35:6140-6149.
    

    >> Share

    
    

    
    Gastrointest Endosc

15. YU CH, Chen KH, Wu JM, Liu CY, et al
    Red Dichromatic Imaging-Guided Peroral Endoscopic Myotomy: A Safer Approach to Achalasia with Concurrent Esophageal Varices (with video).
    Gastrointest Endosc. 2025 Sep 4:S0016-5107(25)01983.
    

    >> Share

    
    

    
    Gut

16. CARLESSI R, Kendall TJ, Olynyk JK, Dwyer BJ, et al
    Disease-associated hepatocytes are predictive of outcomes and survival in MASLD beyond fibrosis staging.
    Gut. 2025 Sep 10:gutjnl-2025-336627. doi: 10.1136/gutjnl-2025-336627.
    

    >> Share

    
    
17. CHAN M, Zhu S, Nukaya M, Ferreira LT, et al
    DNAJ-PKAc fusion heightens PLK1 inhibitor sensitivity in fibrolamellar carcinoma.
    Gut. 2025;74:1680-1693.
    

    >> Share

    
    
18. MA L, Hung MH, Rashidi Mehrabadi F, Wang L, et al
    Beneficial infections of the enterovirus genus in patients with liver cancer.
    Gut. 2025;74:1667-1679.
    

    >> Share

    
    
19. ROSNER T, Rupp C, Lechler C, Bauer U, et al
    Activation of RAS/MEK/ERK signalling drives biliary differentiation in primary liver cancer.
    Gut. 2025 May 12:gutjnl-2024-333238. doi: 10.1136/gutjnl-2024-333238.
    

    >> Share

    
    
20. BU L, Zhang Y, Su Y, Wu X, et al
    High-protein diets alleviate tumour growth and drug resistance by promoting AKT aggregation and turnover.
    Gut. 2025;74:1711-1727.
    

    >> Share

    
    
21. FENG G, Wong VW, Targher G, Byrne CD, et al
    Non-invasive tests of fibrosis in the management of MASLD: revolutionising diagnosis, progression and regression monitoring.
    Gut. 2025;74:1741-1750.
    

    >> Share

    
    

    
    Indian J Gastroenterol

22. ABRAHAM P, Talukdar S, Desai D, Gupta T, et al
    EASL-CLIF, NACSELD and APASL definitions for identification of acute-on-chronic liver failure and its outcome in a non-transplant setting.
    Indian J Gastroenterol. 2025;44:675-683.
    

    >> Share

    
    
23. PANDA K, Dash DP, Panda PK, Dash M, et al
    Role of therapeutic plasma exchange on survival in pediatric acute liver failure and acute-on chronic liver failure: A systematic review and meta-analysis.
    Indian J Gastroenterol. 2025;44:618-633.
    

    >> Share

    
    
24. FERDINANDE K, Groff S, Zanetto A, Labella F, et al
    Transjugular intra-hepatic approach for portal vein stenting in post-inflammatory portal vein stenosis.
    Indian J Gastroenterol. 2025 Sep 11. doi: 10.1007/s12664-025-01873.
    

    >> Share

    
    

    
    Int J Cancer

25. VAN DER GEEST LG, van der Mark M, Verheij J, Farina Sarasqueta A, et al
    Increased incidence, survival, and registration quality of primary hepato-pancreato-biliary cancers in the Netherlands Cancer Registry.
    Int J Cancer. 2025 Sep 12. doi: 10.1002/ijc.70145.
    

    >> Share

    
    

    
    J Gastroenterol Hepatol

26. MAESAKA K, Hikita H, Kai M, Tahata Y, et al
    Hypertension as an Adverse Event Potentially Impacting the Therapeutic Efficacy of Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma.
    J Gastroenterol Hepatol. 2025 Sep 9. doi: 10.1111/jgh.70068.
    

    >> Share

    
    

    
    J Hepatol

27. CLUSMANN J, Balaguer-Montero M, Bassegoda O, Schneider CV, et al
    The barriers for uptake of artificial intelligence in hepatology and how to overcome them.
    J Hepatol. 2025 Jul 16:S0168-8278(25)02337-2. doi: 10.1016/j.jhep.2025.
    

    >> Share

    
    
28. PINATO DJ
    Immunotherapy in advanced hepatocellular cancer: The last piece of the puzzle.
    J Hepatol. 2025 Sep 5:S0168-8278(25)02384-0. doi: 10.1016/j.jhep.2025.
    

    >> Share

    
    
29. FORTEA JI, Alvarado-Tapias E, Simbrunner B, Ezcurra I, et al
    Erratum to 'Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis' [J Hepatol 83 (2025) 70-80].
    J Hepatol. 2025 Sep 5:S0168-8278(25)02439-0. doi: 10.1016/j.jhep.2025.
    

    >> Share

    
    

    
    J Pediatr Surg

30. DAVENPORT M
    Commentary on "Outcomes of Allogenic Umbilical Cord Mesenchymal Stem Cell infusion for Liver Cirrhosis due to Biliary Atresia after Kasai Operation" JPEDSURG-D-25-00654R2.
    J Pediatr Surg. 2025 Sep 5:162649. doi: 10.1016/j.jpedsurg.2025.162649.
    

    >> Share

    
    

    
    N Engl J Med

31. NOUREDDIN M, Shringarpure R, Yale K
    Efruxifermin in Compensated Liver Cirrhosis Caused by MASH. Reply.
    N Engl J Med. 2025;393:10.
    

    >> Share

    
    
32. YU L
    Efruxifermin in Compensated Liver Cirrhosis Caused by MASH.
    N Engl J Med. 2025;393:10.
    

    >> Share

    
    

    
    PLoS One

33. THEUNE LE, Ghoreishi N, Weikert C, Muller-Graf C, et al
    Characteristics of a tattooed population and a possible role of tattoos as a risk factor for chronic diseases: Results from the LIFE-Adult-Study.
    PLoS One. 2025;20:e0319229.
    

    >> Share

    
    
34. CHAI L, Zhou Y, Zhou N, Xiao Y, et al
    Machine learning-based prediction model for 28-day mortality in acute kidney injury patients with liver cirrhosis: A MIMIC-IV database analysis.
    PLoS One. 2025;20:e0328662.
    

    >> Share

    
    

    
    Semin Liver Dis

35. ISRAELSEN M, Trepo E, Krag A, Stender S, et al
    MetALD: Genetic Factors and Clinical Outcomes.
    Semin Liver Dis. 2025;45:269-282.
    

    >> Share

    
    
36. WANG R, Ma F, Yin D, Wang H, et al
    Intestinal Microbes, Metabolites, and Hormones in Alcohol-Associated Liver Disease.
    Semin Liver Dis. 2025;45:283-302.
    

    >> Share

    
    
37. MRAVEC B, Szantova M
    Liver Neurobiology: Regulation of Liver Functions by the Nervous System.
    Semin Liver Dis. 2025;45:420-437.
    

    >> Share

    
    
38. CAO P, Jaeschke H, Ni HM, Ding WX, et al
    The Ways to Die: Cell Death in Liver Pathophysiology.
    Semin Liver Dis. 2025;45:397-419.
    

    >> Share

    
    

    
    Transplant Proc

39. WANG X, Xing N, Yang Q, Ding P, et al
    Catastrophic Outcome of Suspected Seventh-Day Syndrome After Liver Transplantation: Case Report and Literature Review.
    Transplant Proc. 2025 Aug 9:S0041-1345(25)00370.
    

    >> Share

    
    

    
    Transplantation

40. MASPERO M, Sposito C, Wehrle C, Bongini M, et al
    Post-recurrence Survival After Liver Transplantation for Hepatocellular Carcinoma.
    Transplantation. 2025 Sep 8. doi: 10.1097/TP.0000000000005514.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share